Disruption of IκB Kinase (IKK)-mediated RelA Serine 536 Phosphorylation Sensitizes Human Multiple Myeloma Cells to Histone Deacetylase (HDAC) Inhibitors
Open Access
- 1 September 2011
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 286 (39), 34036-34050
- https://doi.org/10.1074/jbc.m111.284216
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effectInvestigational New Drugs, 2010
- Specification of the NF-κB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKKεNucleic Acids Research, 2010
- Histone Deacetylase Inhibitors Activate NF-κB in Human Leukemia Cells through an ATM/NEMO-related PathwayOnline Journal of Public Health Informatics, 2010
- Specification of DNA Binding Activity of NF- B ProteinsCold Spring Harbor Perspectives in Biology, 2009
- The NF- B Family of Transcription Factors and Its RegulationCold Spring Harbor Perspectives in Biology, 2009
- Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and BortezomibSeminars in Hematology, 2009
- Is NF-κB a good target for cancer therapy? Hopes and pitfallsNature Reviews Drug Discovery, 2009
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006